AlphaCore Capital’s iShares iBonds Dec 2025 Term Corporate ETF IBDQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-9,200
Closed -$232K 1432
2025
Q3
$232K Sell
9,200
-1,500
-14% -$37.7K 0.01% 661
2025
Q2
$269K Hold
10,700
0.01% 506
2025
Q1
$269K Buy
+10,700
New +$269K 0.02% 380
2024
Q1
Sell
-10,700
Closed -$265K 240
2023
Q4
$265K Hold
10,700
0.04% 199
2023
Q3
$261K Hold
10,700
0.04% 192
2023
Q2
$261K Hold
10,700
0.04% 180
2023
Q1
$262K Hold
10,700
0.07% 113
2022
Q4
$260K Buy
10,700
+1,950
+22% +$47.2K 0.1% 69
2022
Q3
$211K Buy
8,750
+1,500
+21% +$37K 0.1% 61
2022
Q2
$179K Buy
+7,250
New +$180K 0.08% 71

Other funds holding IBDQ

AlphaCore Capital's IBDQ Position: Q4 2025 in Review

AlphaCore Capital sold out of iShares iBonds Dec 2025 Term Corporate ETF (IBDQ) in Q4 2025, closing a stake of 9,200 shares — an estimated $232K sold.

AlphaCore Capital first reported a position in IBDQ in Q2 2022 and held it in 10 quarters. The position peaked at $269K in Q2 2025. 3 funds tracked by Wall St. Rank hold IBDQ as of Q4 2025.

  • AlphaCore Capital reported no remaining iShares iBonds Dec 2025 Term Corporate ETF position as of Q4 2025 after selling out during the quarter.
  • AlphaCore Capital sold 9,200 iShares iBonds Dec 2025 Term Corporate ETF shares in Q4 2025, an estimated $232K.
  • AlphaCore Capital first reported a position in iShares iBonds Dec 2025 Term Corporate ETF in Q2 2022 and held it in 10 quarters.
  • AlphaCore Capital's iShares iBonds Dec 2025 Term Corporate ETF position peaked at $269K in Q2 2025.
  • 3 funds tracked by Wall St. Rank held iShares iBonds Dec 2025 Term Corporate ETF as of Q4 2025.

Based on AlphaCore Capital's 13F filing for Q4 2025, filed 5 Feb 2026.